Suchergebnisse - "Compagnucci, Alexandra"

PubPharm (40)

1

Follow-up for 3 years of a pediatric population diagnosed in 2018 with mother-to-child transmission of HIV in 8 Latin American countries in the PLANTAIDS cohort

enthalten in: BMC infectious diseases | 2024

von Vallejo, B. | Lobo, A. | García, I. | +43

2

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

3

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents : a secondary analysis of the ODYSSEY trial

enthalten in: The Lancet. Child & adolescent health | 2023

von Turkova, A. | White, E. | Kekitiinwa, A. | +127

4

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV - Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial

enthalten in: EClinicalMedicine | 2023

von Compagnucci, A. | Chan, M. | Saïdi, Y. | +131

5

Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12 years and older : a PK substudy of the SMILE trial

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Abdalla, S. | Compagnucci, A. | Zheng, Y. | +39

6

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis : a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

enthalten in: The lancet. HIV | 2022

von Turkova, A. | Waalewijn, H. | Chan, M. | +121

CommentIn: Lancet HIV. 2022 Sep;9(9):e599-e600. - PMID 35868340

7

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks : results from the below 14 kg cohort in the randomised ODYSSEY trial

enthalten in: The lancet. HIV | 2022

von Amuge, P. | Lugemwa, A. | Wynne, B. | +127

8

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

enthalten in: The New England journal of medicine | 2021

von Turkova, A. | White, E. | Mujuru, H. | +143

9

ODYSSEY clinical trial design : a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

enthalten in: BMC infectious diseases | 2021

von Moore, C. | Turkova, A. | Mujuru, H. | +124

10

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

enthalten in: BMC infectious diseases | 2021

von Moore, C. | Turkova, A. | Mujuru, H. | +23